PHG reports second-quarter results on July 28 with options traders making an unusually bullish bet relative to recent history.
The clearest signal heading into the print is in options positioning. The put/call ratio has collapsed to 0.35 — the lowest reading of the past year, and nearly two standard deviations below its 20-day average of 0.45. That means call volume is dominating puts by a wide margin, an unusually aggressive lean toward upside. The stock itself has given back some ground, down about 3% on the week to $26.17 despite a small recovery on Thursday, so the call-heavy positioning is running against the recent price drift rather than following it.
The lending market is not adding fuel to that bull case, but it is also not contradicting it. Borrow availability has tightened modestly — running at roughly 223% of short interest, its lowest reading in several weeks — but that still represents a normal lending environment with plenty of room for new shorts to enter if sentiment sours post-print. Cost to borrow has edged up 49% over the past month to 1.14%, a notable move in percentage terms but still an objectively cheap rate that does not signal any squeeze pressure. Short interest has climbed about 8% in the past month to roughly 1.77 million shares, a drift higher but not a level that dominates the setup.
The bull case rests on execution. A recent AI note flagged that Philips beat analyst expectations in Q2, citing gains in diagnostic imaging and connected care alongside improving cost discipline. The company's ORTEX short score ranks in the 87th percentile across its universe, and the Piotroski F-Score of 8 points to a healthy balance sheet. Bears can point to a price-to-FCF ratio that has stretched to extreme levels, a PE of 13.5x that has compressed about 2.5 points over 30 days, and an EV/EBITDA of 8.2x that has drifted lower — all suggesting the market has been trimming valuation credit even as the business shows improvement. Analyst data on record is too dated to reference with confidence, but the last meaningful cluster of moves, between late 2024 and early 2025, was skewed toward upgrades from UBS and JPMorgan — a constructive backdrop that the stock has not fully translated into price appreciation since.
On the ownership side, Lingotto Investment Management holds a dominant 18.8% stake, and Dodge & Cox added nearly 4.8 million shares in the latest reported period — a material addition for a value-oriented manager that signals conviction in the current price range. Insider activity reinforces that read: two supervisory board members made open-market purchases in May at prices just below current levels, modest in size but directionally consistent.
The July 28 report will therefore test whether the diagnostic imaging momentum cited in Philips' own commentary can translate into guidance that justifies the call-skewed positioning — or whether the valuation compression of the past month was the market pricing in a more cautious outlook ahead.
See the live data behind this article on ORTEX.
Open PHG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
